BioSpace News Archive

Interactive Strength Inc. d/b/a FORME (the “Company”, or “FORME”) (NASDAQ: TRNR), today announced its financial results for the first quarter of 2023.

The Institute for Protein Innovation (IPI) , today announced a strategic partnership to accelerate biomedical research and therapeutic development through the discovery, development, and distribution of recombinant antibodies and other protein and DNA reagents.

Repare Therapeutics Inc. today announced that members of its senior management team will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on Wednesday, June 14, 2023 at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time in Dana Point, California.

Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases.

Bausch + Lomb Corporation today announced that researchers will present the results of 11 scientific poster presentations involving the company’s consumer, vision care and pharmaceutical products during the American Optometric Association (AOA) Optometry’s Meeting e-posters Virtual Event, which is taking place from June 13-14, 2023.

Inversago Pharma to Present Data from Phase 1b Trial of INV-202, a Peripheral CB1r Blocker for Metabolic Syndrome, at the 83rd American Diabetes Association Scientific Sessions.

Aclarion, Inc. announced today their Nociscan cost-effectiveness abstract was presented at the International Society for the Advancement of Spine Surgery on Saturday, June 3, 2023.

Syros Pharmaceuticals today announced that its Chief Executive Officer, Nancy Simonian, M.D., will present a corporate overview at the Sidoti June 2023 Virtual Small-Cap Conference. Management will also be available for one-on-one meetings.

Roche Diagnostics, a division of Hoffmann-La Roche Limited, is proud to announce Health Canada approval for its Cerebrospinal Fluid (CSF) assays* to measure three biomarkers that are hallmarks of Alzheimer’s pathology, beta-amyloid and tau proteins, in adults aged 55 and older being evaluated for the disease.

Indica Labs today announces the launch of a service offering deployment and on-going support of its HALO ® digital pathology software in a fully managed cloud-hosted environment powered by Amazon Web Services (AWS).